Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

Structural Heart
Medtronic Begins Multicenter Study to Address Health Disparities in Structural Heart Disease Care
11/20/2024
The study will utilize the Tempus Next platform to identify severe aortic stenosis or moderate to severe mitral regurgitation patients who meet guideline indicated therapy criteria, but do not have a treatment plan in place.
The study will utilize the Tempus Next platform to identify severe aortic stenosis or moderate to severe mitral regurgitation patients who meet guideline indicated therapy criteria, but do not have a treatment plan in place.
The study will utilize the...
11/20/2024
Cath Lab Digest
Heart research
Study: Genetic Information Related to Heart Shape Can Provide Risk Score for Heart Disease
11/18/2024
"We've long known that size and volume of the heart matter, but by examining shape, we're uncovering new insights into genetic risks," said study co-author Professor Patricia B. Munroe. Researchers are the first to examine the genetic basis...
"We've long known that size and volume of the heart matter, but by examining shape, we're uncovering new insights into genetic risks," said study co-author Professor Patricia B. Munroe. Researchers are the first to examine the genetic basis...
"We've long known that size and...
11/18/2024
Cath Lab Digest
Coronary Calcium Scores
Intermountain Health Study Finds Prognostic Value of Coronary Calcium Scores Effective in Predicting Risk of Heart Attack
11/18/2024
A major new study by Intermountain Health researchers finds coronary artery calcium scores are not only highly effective in identifying those at risk for future heart attacks, but also for death, and risk prediction was found to be as good in...
A major new study by Intermountain Health researchers finds coronary artery calcium scores are not only highly effective in identifying those at risk for future heart attacks, but also for death, and risk prediction was found to be as good in...
A major new study by...
11/18/2024
Cath Lab Digest

Advertisement

spironolactone
CLEAR SYNERGY Trial: Spironolactone May Reduce Heart Failure Risk But Did Not Significantly Impact Rate of Death, New Heart Attack, or Stroke
11/18/2024
“While spironolactone didn’t reduce deaths or other major heart complications after a heart attack, it did reduce the likelihood of heart failure, which is an important finding for patients and health care professionals," said Sanjit Jolly,...
“While spironolactone didn’t reduce deaths or other major heart complications after a heart attack, it did reduce the likelihood of heart failure, which is an important finding for patients and health care professionals," said Sanjit Jolly,...
“While spironolactone didn’t...
11/18/2024
Cath Lab Digest
Patient Care
AHA: Fear of Another Heart Attack May Be Major Source of Ongoing Stress for Survivors
11/18/2024
The researchers suggest that fear of another heart attack should be evaluated and addressed separately from depression and anxiety. In the survey, the fear of another heart attack was significant at 6 months after the heart attack and still...
The researchers suggest that fear of another heart attack should be evaluated and addressed separately from depression and anxiety. In the survey, the fear of another heart attack was significant at 6 months after the heart attack and still...
The researchers suggest that...
11/18/2024
Cath Lab Digest
Sex Differences
JAMA Network Open: First Extensive Investigation of Sex-Specific Differences in Cerebral Small Vessel Disease
11/18/2024
Men are more frequently affected by cerebral microbleeds (CMBs)—around 28% of patients had at least one microbleeding event, whereby the prevalence in men was significantly higher than in women. In contrast, women appeared to suffer damage to...
Men are more frequently affected by cerebral microbleeds (CMBs)—around 28% of patients had at least one microbleeding event, whereby the prevalence in men was significantly higher than in women. In contrast, women appeared to suffer damage to...
Men are more frequently affected...
11/18/2024
Cath Lab Digest

Advertisement

Kidney Transpant & CVD/Stroke Risk
Innovative Risk Score Accurately Calculates Which Kidney Transplant Candidates Are Also at Risk for Heart Attack or Stroke, Intermountain Health Study Finds
11/18/2024
Using an innovative risk score assessment score, heart researchers at Intermountain Health in Salt Lake City say they can accurately predict whether patients being assessed for kidney transplant will likely have a future major cardiac event,...
Using an innovative risk score assessment score, heart researchers at Intermountain Health in Salt Lake City say they can accurately predict whether patients being assessed for kidney transplant will likely have a future major cardiac event,...
Using an innovative risk score...
11/18/2024
Cath Lab Digest
Inflammation
AHA: Air Pollution Increases Inflammation Primarily in Patients With Heart Disease
11/18/2024
"Individuals with known heart disease, including those diagnosed with heart failure, need to be especially cautious during periods of poor air quality. This includes exercising indoors, making sure to take their prescribed medications, and...
"Individuals with known heart disease, including those diagnosed with heart failure, need to be especially cautious during periods of poor air quality. This includes exercising indoors, making sure to take their prescribed medications, and...
"Individuals with known heart...
11/18/2024
Cath Lab Digest
Bleeding Reduction
AHA: AZALEA-TIMI 71 Study Demonstrates Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban
11/18/2024
"Given the elevated bleeding risks associated with traditional anticoagulants, particularly when combined with antiplatelet agents, abelacimab may offer a safer alternative for patients with atrial fibrillation,” said Christian T. Ruff, MD,...
"Given the elevated bleeding risks associated with traditional anticoagulants, particularly when combined with antiplatelet agents, abelacimab may offer a safer alternative for patients with atrial fibrillation,” said Christian T. Ruff, MD,...
"Given the elevated bleeding...
11/18/2024
Cath Lab Digest

Advertisement

LAA Closure
Boston Scientific Watchman FLX Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial
11/18/2024
"The OPTION trial data provide clinical evidence indicating that, among patients who have undergone an ablation, LAAC with the Watchman FLX device is not only as safe, but superior to OAC therapy for reducing the risk of long-term bleeding...
"The OPTION trial data provide clinical evidence indicating that, among patients who have undergone an ablation, LAAC with the Watchman FLX device is not only as safe, but superior to OAC therapy for reducing the risk of long-term bleeding...
"The OPTION trial data provide...
11/18/2024
Cath Lab Digest

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use